Areas of Focus
Cardiac Diseases
Cardiomyopathies and heart failure are prevalent life-threatening cardiac conditions caused by impaired myocardial function, serving as key therapeutic targets for cardiac-targeted siRNA delive...
Cardiovascular and Metabolic Diseases
Leveraging mature hepatic targeting strategies and optimized oligonucleotide modification systems, Youngen’s liver-targeted delivery pipeline enables efficient, stable, and high-specificity accumulat...
Renal Disorders
Hair loss is a type of skin disease, and the common types of hair loss are mainly divided into androgenic alopecia, alopecia areata, psychogenic alopecia, genetic alopecia, etc. 95% of the hair loss belongs to androgenic alopecia.
CNS Disorders
Hair loss is a type of skin disease, and the common types of hair loss are mainly divided into androgenic alopecia, alopecia areata, psychogenic alopecia, genetic alopecia, etc. 95% of the hair loss belongs to androgenic alopecia.
As a biotech solutions ltd, we will do our best to meet all the needs of customers.
If you want to know more about biotech solutions, please visit our website.
Youngen, based in Beijing, is a leading oligonucleotide therapeutic company built around AOC modality. Youngen has been dedicated to develop RNAi therapeutics to a broad spectrum of difficult-to-treat diseases, both rare and general, impacting millions of people and families around the world. Leveraging cutting-edge technological platforms, we build globally competitive diversified product pipelines with first-in-classband Best-in-class potentials.We are advancing programs across key therapeutic areas, including cardiovascular, renal, central nervous system (CNS), and metabolic diseases, to deliver novel treatment options for patients in need.
There are many biomedical companies, but we are one of the best choices for you.
You must be logged in to post a comment.